新华制药(000756) - 2018 Q3 - 季度财报

Financial Performance - Operating revenue for the current period was CNY 1,272,009,512.28, representing a 21.21% increase year-on-year[9] - Net profit attributable to shareholders was CNY 69,967,386.26, a 4.59% increase compared to the same period last year[9] - Net profit attributable to shareholders after deducting non-recurring gains and losses increased by 65.71% to CNY 55,567,578.40[9] - Basic earnings per share remained at CNY 0.11, unchanged from the previous period[9] - The weighted average return on equity was 2.71%, a decrease of 0.38% compared to the previous year[9] Asset and Liability Changes - Total assets increased by 8.89% to CNY 5,742,323,207.45 compared to the end of the previous year[9] - Net assets attributable to shareholders increased by 5.76% to CNY 2,622,895,804.88 compared to the end of the previous year[9] - As of September 30, 2018, the group's accounts receivable and notes receivable amounted to RMB 681,446,553.95, an increase of 56.34% compared to the beginning of the year, primarily due to expanded sales scale and payment terms not yet reached[18] - As of September 30, 2018, the group's prepayments were RMB 53,823,257.09, up 136.00% from the beginning of the year, mainly to ensure normal production and increased procurement payments[18] - As of September 30, 2018, the group's short-term borrowings were RMB 235,334,092.21, an increase of 54.99% from the beginning of the year, primarily to supplement working capital[18] Expenses and Investments - Sales expenses for Q3 2018 were RMB 163,457,382.85, an increase of 49.62% year-on-year, driven by active market expansion and increased brand influence[18] - R&D expenses for Q3 2018 were RMB 54,006,848.91, up 62.86% year-on-year, reflecting increased investment in research and development[19] - The net cash flow from investing activities for the first nine months of 2018 was RMB -218,859,575.60, a decrease of 71.00% year-on-year, due to reduced cash recovery from the disposal of long-term assets[20] - The net cash flow from financing activities for the first nine months of 2018 was RMB 64,982,887.60, down 70.12% year-on-year, primarily due to the previous year's non-public offering of stock[20] - As of September 30, 2018, the group's construction in progress was RMB 588,341,806.82, an increase of 35.39% from the beginning of the year, indicating ongoing project investments[18] Shareholder Information - The company implemented a capital reserve conversion plan, increasing shares by 30% for every 10 shares held[8] - The total number of shareholders at the end of the reporting period was 31,361[13] Tax and Employee Compensation - The group's deferred tax liabilities as of September 30, 2018, were RMB 31,667,092.13, increased due to tax policy changes allowing one-time deductions for certain equipment depreciation[18] - The group's employee compensation payable as of September 30, 2018, was RMB 29,761,516.91, a decrease of 56.53% from the beginning of the year, due to payments made during the reporting period[18]